Thus, unsurprisingly, the knockdown of TMPO-AS1 suppressed growth and increased apoptosis in thyroid cancer (76), glioma progression (77), and cell proliferation and motility in pancreatic carcinoma (72). Here, TMPO is linked to exocrine pancreatic carcinoma.